NMDA antagonist
AssigneeImperial College of Science, Technology and Medicine
InventorsNicholas Peter Franks, Mervyn Maze
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of xenon as an NMDA antagonist. In particular, the invention relates to a method of treatment comprising modulating the activity of an NMDA receptor in a mammal, the method comprising modulating the activity of the NMDA receptor by administering to the mammal a therapeutically effective amount of xenon. In a further aspect, the invention provides a process for the preparation of a pharmaceutical composition suitable for modulating the activity of an NMDA receptor.
Claims10
A method for providing neuroprotection, relieving neuropathic pain, or inhibiting synaptic plasticity in a mammal comprising administering to a mammal in need thereof xenon in an amount effective to modulate the activity of an NMDA receptor in said mammal.
Dependencies are inferred from the claim text.